Viridian Therapeutics (UK) Market Value
| 0K1R Stock | 16.73 0.53 3.07% |
| Symbol | Viridian |
Viridian Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Viridian Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Viridian Therapeutics.
| 07/02/2024 |
| 08/01/2024 |
If you would invest 0.00 in Viridian Therapeutics on July 2, 2024 and sell it all today you would earn a total of 0.00 from holding Viridian Therapeutics or generate 0.0% return on investment in Viridian Therapeutics over 30 days. Viridian Therapeutics is related to or competes with Rightmove PLC, Bioventix, 4Imprint Group, and Auto Trader. Viridian Therapeutics is entity of United Kingdom More
Viridian Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Viridian Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Viridian Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.88 | |||
| Information Ratio | 0.0766 | |||
| Maximum Drawdown | 18.63 | |||
| Value At Risk | (5.89) | |||
| Potential Upside | 7.07 |
Viridian Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viridian Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Viridian Therapeutics' standard deviation. In reality, there are many statistical measures that can use Viridian Therapeutics historical prices to predict the future Viridian Therapeutics' volatility.| Risk Adjusted Performance | 0.077 | |||
| Jensen Alpha | 0.3291 | |||
| Total Risk Alpha | (0.15) | |||
| Sortino Ratio | 0.0765 | |||
| Treynor Ratio | 0.5975 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viridian Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Viridian Therapeutics Backtested Returns
Currently, Viridian Therapeutics is somewhat reliable. Viridian Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0511, which indicates the firm had a 0.0511% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Viridian Therapeutics, which you can use to evaluate the volatility of the company. Please validate Viridian Therapeutics' Risk Adjusted Performance of 0.077, coefficient of variation of 972.1, and Semi Deviation of 3.5 to confirm if the risk estimate we provide is consistent with the expected return of 0.19%. Viridian Therapeutics has a performance score of 3 on a scale of 0 to 100. The entity has a beta of 0.65, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Viridian Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Viridian Therapeutics is expected to be smaller as well. Viridian Therapeutics right now has a risk of 3.79%. Please validate Viridian Therapeutics jensen alpha, sortino ratio, and the relationship between the standard deviation and total risk alpha , to decide if Viridian Therapeutics will be following its existing price patterns.
Auto-correlation | 0.69 |
Good predictability
Viridian Therapeutics has good predictability. Overlapping area represents the amount of predictability between Viridian Therapeutics time series from 2nd of July 2024 to 17th of July 2024 and 17th of July 2024 to 1st of August 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Viridian Therapeutics price movement. The serial correlation of 0.69 indicates that around 69.0% of current Viridian Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 0.99 |
Viridian Therapeutics lagged returns against current returns
Autocorrelation, which is Viridian Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Viridian Therapeutics' stock expected returns. We can calculate the autocorrelation of Viridian Therapeutics returns to help us make a trade decision. For example, suppose you find that Viridian Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Viridian Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Viridian Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Viridian Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Viridian Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Viridian Therapeutics Lagged Returns
When evaluating Viridian Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Viridian Therapeutics stock have on its future price. Viridian Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Viridian Therapeutics autocorrelation shows the relationship between Viridian Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Viridian Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| TRPL4 | CTEEP Companhia | |
| SAPR11 | Companhia de Saneamento | |
| NEOE3 | Neoenergia SA |
Additional Tools for Viridian Stock Analysis
When running Viridian Therapeutics' price analysis, check to measure Viridian Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viridian Therapeutics is operating at the current time. Most of Viridian Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viridian Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viridian Therapeutics' price. Additionally, you may evaluate how the addition of Viridian Therapeutics to your portfolios can decrease your overall portfolio volatility.